Dr. med. Arthur Hammer

2023 – 2024

Moorfields eye hospital NHS Foundation Trust, Service de cornée, surface oculaire et chirurgie réfractive, Londres, Royaume-Uni‍

Médecin cadre (Bank consultant ophthalmologist)

2023 – 2024

Hôpital ophtalmique Jules Gonin, Unité de Cornée et Chirurgie réfractive, Département d’ophtalmologie du CHUV, Lausanne, Suisse

Médecin Praticien Hospitalier (MPH)

2021 – 2023

Moorfields eye hospital NHS Foundation Trust, Service de cornée, surface oculaire et chirurgie réfractive, Londres, Royaume Uni

Fellow (activité chirurgicale et médicale)

Fev 2020 – Juil 2021

Moorfields eye hospital NHS Foundation Trust, Service de Cataracte, Londres, Royaume Uni

Fellow (activité chirurgicale et médicale)

Nov 2018 – Jan 2020

North West Anglia NHS Foundation Trust, Peterborough city hospital – Service d’ophtalmologie, Peterborough, Royaume Uni

Médecin assistant (4ème et 5ème années de formation)

2015 – 2018

Hôpital ophtalmique Jules Gonin, Département d’ophtalmologie du CHUV, Lausanne, Suisse

Médecin assistant (1ère, 2ème et 3ème années de formation)

2019 – 2022

Formation postgrade approfondie (FMH) en ophtalmo-chirurgie – Obtenu Août 2022

2015 – 2019

Titre de spécialiste postgrade fédéral (FMH) en ophtalmologie – Obtenu Février 2020

2012 – 2015

Département des Neurosciences Cliniques, Division d’Ophtalmologie, Hôpitaux Universitaires de Genève (HUG), Genève, Suisse
MD-PhD en cornée et chirurgie réfractive (Cross-linking de la cornée: limitations, molécules impliquées et effet sur l’œdème de cornée)

2006 – 2012

Université de Genève (UNIGE), Suisse – Faculté de Médecine
Diplôme fédéral en médecine humaine

2010 – 2011

Département d’oncologie, Division de radio-oncologie, Hôpitaux Universitaires de Genève (HUG), Genève, Suisse
Thèse de Master, Recherche Clinique en radio-oncologie

2019

ESCRS, prix du meilleur poster de la session « Refractive Surgery: Can Results Improve Even Further? » (reprélsentation par Dr Emilio Torres-Netto)

2014

ASCRS, prix du Meilleur article de la session « CORNEA – Rings and Crosslinking: Corneal Collagen Cross Linking Oxygen Dependency »

2013

SSO/SOG Prix du Meilleur poster de recherche expérimentale (1000 CHF) – CXL Oxygen Dependency

‍
‍Fond National Suisse de Recherche – Programme MD-PhD (180’000 CHF)

‍
‍ASCRS, prix du “Poster of Interest in Cornea” – Corneal Biomechanical Properties at Different Fluency’s (représentation par Dr. Olivier Richoz)

2025

FEBOS-CR – Examen de sous-spécialité en cataracte et chirurgie réfractive de l’EBO/ESCRS - Examinateur

2025

European Society of Cataract and Refractive Surgery (ESCRS) annual meeting - Reviewer des abstracts soumis pour présentations et poster

2023-présent

Journal of Cataract and Refractive Surgery (JCRS) - Reviewer d'articles scientifiques soumis pour publication

2013

European Journal of Ophthalmology (EJO) - Reviewer d'articles scientifiques soumis pour publication

2025

Directeur du cours: THE LOST ART OF PENETRATING KERATOPLASTY: A COMPREHENSIVE GUIDE FORBEGINNERS. ESCRS 2025, Copenhague.

2024

Diplôme de spécialité en chirurgie de la cataracte et réfractive FEBOS-CR / European Board of Ophthalmology (EBO) et Société Européenne de Chirurgie de la Cataracte et Réfractive (ESCRS)

2023

Certificate of Laser and Refractive Surgery (CertLRS), Royal College of Ophthalmologists, London, UK- Réussi et obtenu

‍
Post Graduate Diploma in Cataract and Refractive Surgery (PGDip CRS), Ulster University, Northern Ireland – Réussi et obtenu avec distinction

2022

Forefront therapeutic refractive surgery course (London vision clinic)

‍
Forefront refractive surgery course: LASIK, presbyopia correction & SMILE (London vision clinic)

2021

Examen fédéral suisse de formation approfondie en ophtalmo-chirurgie (diplôme FMH) – Réussi et obtenu

2019

Examen et Diplôme Européen d’ophtalmologie, European board of ophthalmology (EBO) – Réussi et Obtenu

‍
Microsurgical skills course (The royal college of ophthalmologists)

2018

Examen d’ophtalmologie clinique, International Council of Ophthalmology (ICO) – Réussi

2015

Basic science and refraction (International council of ophthalmology) – Réussi

‍
Examen de Scienses Visuelles, International Council of Ophthalmology (ICO) – Réussi

‍
Examen d’Optique, Réfraction et Instruments, International Council of Ophthalmology (ICO) – Réussi

2014

LTK Module 2: Formation pour les personnes responsables de diriger des expérimentations animales (FELASA C), Fédération des vétérinaires cantonaux, Lausanne, Suisse

2013

Introduction à la science de laboratoire des animaux (module 1 – FELASA B), RESEAL (Lemanic Animal Facility Network) Lausanne, Suisse

‍
Cours PhD: Essentials in Molecular and Applied Pharmacology, UNIGE, Section des Sciences Pharmaceutiques, Genéve, Suisse

‍
Cours PhD: Cancer, UNIGE, Genève, Suisse

‍
Cours PhD: Virologie, UNIGE, Genève, Suisse

‍
Cours PhD: Interactions cellulaires, UNIGE, Genève, Suisse

Fédération des Médecins Helvétiques (FMH)

Société Suisse d’Ophtalmologie (SSO)

Société Vaudoise de Médecine (SVM)

Association des Médecins du Canton de Genève (AMGe)

Société Médicale du Valais (SVMS)

Fellow of the European Board of Ophthalmology (FEBO)

European Society of Cataract and Refractive Surgery (ESCRS)

ESCRS’ Young Ophthalmologists For Sustainability (YOFS)

FEBOS-CR - Membre alumni

Fellow of the World College of Refractive Surgery and Visual Sciences (WCRSVS)

Hammer A, Takaza A, Lane M, Rahman A, Vasquez-Perez A. Donor-implantedGuttata in Transplanted Corneal Tissue: Clinical Signs and Impact on GraftSurvival. J Ophthalmic Vis Res. 2025 Sep 9.

Ashton CBJ, Hammer A, Heeren TFC, Allan BD, Maurino V, Gore DM. A Comparison of Predicted and Achieved Postoperative Vaults in Implantable Collamer Lenses in White and Asian Eyes. J Refract Surg. 2025 Jul.

Hammer A, Heeren TFC, Angunawela R, Marshall J, Saha K. A Novel Role for Corneal Pachymetry in Planning Cataract Surgery by Determining Changes in Spherical Equivalent Resulting from a Previous LASIK Treatment. J Ophthalmol. 2023 May 31;2023

Hammer A, Borruat FX. Case Report: Multimodal Imaging of Toxic Retinopathies Related to Human Immunodeficiency Virus Antiretroviral Therapies: Maculopathy vs. Peripheral Retinopathy. Report of Two Cases and Review of the Literature. Front Neurol. 2021 Jun 17;12:663297.

Lopez Baumann S, Rossi DC, Hammer A, Chave JP, Guex-Crosier Y. Superficial and Deep Macular Vessel Occlusion in West Nile Virus. Klin Monbl Augenheilkd. 2019 Apr;236(4):590-593.

Kling S, Hammer A, Netto EAT, Hafezi F. Differential Gene Transcription of Extracellular Matrix Components in Response to In Vivo Corneal Crosslinking (CXL) in Rabbit Corneas. Transl Vis Sci Technol. 2017 Dec 12;6(6):8.

Kling S, Hammer A, Conti A, Hafezi F. Corneal Cross-Linking with Riboflavin and UV-A in the Mouse Cornea in Vivo: Morphological, Biochemical, and Physiological Analysis. Transl Vis Sci Technol. 2017 Jan 30;6(1):7.

Tabibian D, Kling S, Hammer A, Richoz O, Hafezi F. Repeated Cross-linking After a Short Time Does Not Provide Any Additional Biomechanical Stiffness in the Mouse Cornea In Vivo. J Refract Surg. 2017 Jan 1;33(1):56-60.

Hammer A, Rudaz S, Guinchard S, Kilng S, Richoz O, Hafezi F. Analysis of riboflavin compounds in the rabbit cornea in vivo. Curr Eye Res. 2016 Sep;41(9):1166-72.

Kling S, Richoz O, Hammer A, Tabibian D, Jacob S, Agarwal A, Hafezi F. Increased Biomechanical Efficacy of Corneal Cross-linking in Thin Corneas Due to Higher Oxygen Availability. J Refract Surg. 2015 Dec;31(12):840-6.

Hammer A, Kling S, Marc-Olivier Boldi, Olivier Richoz, David Tabibian, J. Bradley Randleman, Farhad Hafezi. Establishing Corneal Cross-Linking with riboflavin and UV-A in the mouse cornea in vivo: biomechanical analysis. Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6581-90.

Richoz O, Kling S, Hoogewoud F, Hammer A, Tabibian D, François P, Schrenzel J, Hafezi F. Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL). J Refract Surg. 2014 Dec;30(12):850-4

Richoz O, Mosquera S, Kling S, Hammer A, Magnago T, Bosch M, Hafezi F. Determination of the excimer laser ablation rate in previously cross-linked corneas. J Refract Surg. 2014 Sep;30(9):628-32.

Richoz O, Kling S, Zandi S, Hammer A, Spoerl E, Hafezi F. A constant force technique to measure corneal biomechanical changes after collagen cross-linking. PLoS One. 2014 Aug 27;9(8)

Richoz O, Tabibian D, Hammer A, Majo F, Nicolas M, Hafezi F. The effect of standard and high-fluence corneal cross-linking (CXL) on cornea and limbus. Invest Ophthalmol Vis Sci. 2014 Jul 22;55(9):5783-7.

Hammer A, Tabibian D, Richoz O, Hafezi F. Keratoconus treatment by corneal cross-linking (CXL). Rev Med Suisse 2014 Juin; 10: 1263-1265

Hammer A, Mosquera S, Magnano T, Richoz O, Tabibbian T, Hoogewoud F, Hafezi F. Corneal Biomechanical Properties at Different Corneal Cross-Linking (CXL) Irradiances. Invest Ophthalmol Vis Sci. 2014 May 2; 55(5): 2881-4

Richoz O, Hammer A, Hafezi F. The Biomechanical Effect of Corneal Collagen Cross-Linking (CXL) With Riboflavin and UV-A is Oxygen Dependent. Transl Vis Sci Technol. 2013 Nov; 2(7): 6

Ghazi A, Zimmermann N, Nguyen C, Hammer A. Applicability of the CPT ratio with MS39 to determine the spherical equivalent of ablation of a previous corneal laser vision correction with SMILE, LASIK, presby-LASIK and PRK. Étude en cours. Swiss Visio Network.

Hammer A. Avoiding Complications : Importance of a Standardized surgical approach. EVO ICL™MASTERCLASS Advanced Surgical Workshop. Zurich, décembre 2025

Hammer A. Navigating Complex Cases. EVO ICL™ MASTERCLASS Advanced Surgical Workshop. Zurich, Décembre 2025

Hammer A. Pre-Operative Fundamentals of Anterior Segment Measurements. EVO ICL™MASTERCLASS Advanced Surgical Workshop. Zurich, décembre 2025

Hammer A. Strategies to Engage Patients. EVO ICL™ MASTERCLASS Advanced Surgical Workshop. Zurich, Décembre2025

Hammer A. Comment planifier la chirurgie de la cataracte chez les patients avec antécédents de chirurgie réfractive. Formation post-graduée, Swiss Visio, Lausanne, novembre 2025

Hammer A. Dysphotopsies positives et négatives. Formation post-graduée, Swiss Visio, Lausanne, novembre 2025

Hammer A. Comment planifier et prendre en charge les cataractes complexes : pathologies cornéennes. Formation post-graduée, Swiss Visio, Lausanne, octobre 2025

Hammer A. Décompensation cornéenne endothéliale : diagnostique et prise en charge. Formation post-graduée, Swiss Visio, Lausanne, septembre 2025

Hammer A. Le kératocône de A à Z: Prise en charge optique, médicale et chirurgicale. Formation post-graduée, Swiss Visio, Lausanne, septembre 2025

Hammer A. Principales dystrophies cornéennes à connaître : Classification, diagnostic et prise en charge. OPT-X, congrès pour l’optométrie et l’optique Suisse, Baden, septembre 2025.

Hammer A. Planification de la chirurgie de la cataracte après une chirurgie réfractive au laser : Éviter la surprise réfractive postopératoire. OPT-X, congrès pour l’optométrie et l’optique Suisse, Baden, septembre 2025.

Hammer A. General introduction, pre-operative assessment and preparation to penetrating keratoplasty. Instructional course: THE LOST ART OF PENETRATING KERATOPLASTY: A COMPREHENSIVE GUIDE FORBEGINNERS. ESCRS 2025, September, Copenhagen, Denmark.

Hammer A. Graft rejection and failed penetrating keratoplasty: how to recognize and manage them. Instructional course: THE LOST ART OF PENETRATING KERATOPLASTY: A COMPREHENSIVE GUIDE FORBEGINNERS. ESCRS 2025, September, Copenhagen, Denmark.

Hammer A. Prise en charge réfractive thérapeutique complexe du kératocône. Congrès annuel “Actualités en chirurgie réfractive, cataracte et cornée”, juin 2025, Genève, Suisse.

Hammer A. Sustainability in refractive surgery. SOE 2025, June, Lisbon, Portugal.

Hammer A. Management of complex situations with ICL: Keratoconic and presbyopic patients with high visual demands. International EVO young eye surgeons meeting. Prague, April 2025.

Hammer A. Keratoconus management A to Z: Optical, Medical and Surgical. Congrès annuel de l'AOR, avril 2025

Hammer A. Avoiding refractive surprise when planning cataract surgery for Laser Vision Correction (LVC) patients. Jeudi de Jules Gonin, Hot topics in cornea and refractive surgery. Hôpital ophtalmique Jules Gonin. Décembre 2024. Lausanne, Suisse

Hammer A. Endothelial decompensation: current management and future perspectives. Centre Neuchâtelois d’ophtalmologie. Décembre 2024. Neuchâtel, Suisse

Hammer A. Positive and negative dysphotopsia (without positive effects for the patient and the surgeon). Centre Neuchâtelois d’ophtalmologie. Décembre 2024. Neuchâtel, Suisse

Hammer A. Cours aux médecins généralistes: questions/réponses et discussions avec présentations de cas ophtalmologie. Cours aux médecins généralistes de la Clinique La Source. Novembre 2024, Lausanne, Suisse

Hammer A. Glare and Haloes. The Cataract Circle Meeting. November 2024. Zurich, Switzerland

Hammer A. Avoiding refractive surprise when planning cataract surgery for Laser Vision Correction (LVC) patients. The Cataract Circle Meeting. November 2024. Zurich, Switzerland

Hammer A. Planning cataract surgery: corneal pathologies. The Cataract Circle Meeting. November 2024. Zurich, Switzerland

Hammer A. Dysphotopsies positives et négatives: étiologies, diagnostique et prise en charge. Cours post-gradué aux assistants et chefs de clinique Swiss Visio. Lausanne, Suisse. Novembre 2024

Hammer A. Comment planifier la chirurgie de la cataracte chez les patients avec antécédents de chirurgie réfractive. Cours post-gradué aux assistants et chefs de clinique Swiss Visio. Lausanne, Suisse. Novembre 2024

Hammer A. Comment planifier et prendre en charge les cataractes complexes: Pathologies cornéennes. Cours post-gradué aux assistants et chefs de clinique Swiss Visio. Lausanne, Suisse. Octobre 2024

Hammer A. LASIK over LASIK, Don’t PANIC. Vision Laser. Wine and See: Complex refractive surgery cases discussion between local experts. Geneva, Switzerland. October 2024

Hammer A. Corneal endothelial decompensation: current management and future perspectives. Swiss visio post graduate teaching. Lausanne, Switzerland. September 2024

Hammer A. Atopic and vernal keratoconjunctivitis: The basics (not so basic…). Swiss visio post graduate teaching. Lausanne, Switzerland. September 2024

Hammer A. Corneal endothelial decompensation: current management and future perspectives. Actualités en ophtalmologie, Geneva, Switzerland. June 2024

Hammer A. Atopic and vernal keratoconjunctivitis: The basics (not so basic…). Society for Ophthalmo-Immunoinfectiology in Europe. Lausanne, Switzerland. June 2024

Hammer A. Bases en ophtalmologie pour le médecin généraliste et quand référer à un spécialiste. Cours aux médecins généralistes de la Clinique La Source. Mai 2024, Lausanne, Suisse

Hammer A. Greffes de cornée: évolution vers les techniques lamellaires : état actuel et avancées à venir. Swiss visio post graduate teaching. Lausanne, Switzerland. April 2024

Hammer A. Endothelium under pressure: cornea and glaucoma specialist interactions. WebUp Expert Forum “Update Ophthalmology”. Online teaching, Switzerland February 2024

Hammer A. Planification de la chirurgie de la cataracte chez les patients avec antécédents de chirurgie réfractive cornéenne au laser. Swiss visio post graduate teaching. Lausanne, Switzerland. December 2023

Hammer A. Endothélium sous pression: relations et collaboration entre spécialistes du glaucome et de la cornée. Swiss visio post graduate teaching. Lausanne Switzerland. November 2023

Hammer A., Li O, Gore D, Allan B. E-F-Dalk: Cut Parameters For Hybrid Excimer And Femtosecond Laser Assisted Deep Anterior Lamellar Keratoplasty – Pilot Experimentation. ESCRS annual meeting, Milan, September 2022

Hammer A., Allan B. Query on management plan for a patient with dense central full thickness corneal: should we treat the neovascularization prior to doing the penetrating keratoplasty? Grand rounds of cornea and external diseases. Moorfields eye hospital, NHS foundation trust, London, United Kingdom. October 2021

Hammer A. IOL choices for DMEK patients: Triple procedure vs sequential. Cornea and external diseases teaching. Moorfields eye hospital, NHS foundation trust, London, United Kingdom. October 2021

Hammer A. IOL exchange: Indications and surgical techniques/pearls. Cornea and external diseases teaching. Moorfields eye hospital, NHS foundation trust, London, United Kingdom. July 2021

Hammer A., Minos E. Ozurdex treatment for diabetic macular edema. AUDIT on compliance with NICE guidelines. North West Anglia NHS Foundation Trust, Peterborough city hospital, Peterborough, United Kingdom. July 2019

Hammer A. Ocular Rosacea: pathophysiology, clinical aspects, workup and management. Anterior segment teaching session. North West Anglia NHS Foundation Trust, Peterborough city hospital, Peterborough, United Kingdom. February 2019

Hammer A., Jorge Ruiz-Medrano, Ann Schalenbourg. PHACE syndrome. Resident day 2017. Hôpital ophtalmique Jules Gonin, Lausanne, Suisse

Hammer A., Kling S, Boldi M-O, Richoz O, Tabibian D, Hafezi F. Establishing corneal cross-linking in mice: biomechanical analysis. EuCornea 2015, Barcelona, Spain

Kling S, Hammer A, Richoz O, Hafezi F. The Effect of Pulsed Cross-linking on Corneal Biomechanics. ESCRS 2015, Barcelona, Spain

Kling S, Hammer A, Richoz O, Hafezi F. Biomechanical Efficacy of UV Cross-Linking Protocols in Thin versus Thick Corneas. EuCornea 2015, Barcelona, Spain

Tabibian D, Kling S, Hammer A, Richoz O, Hafezi F. No additional biomechanical effect of CXL after repeated in vivo treatment in mice. EUCornea 2015. Barcelona, Spain

Kling S, Hammer A, Richoz O, Tabibian D, Hafezi F. Establishing UV Collagen Cross-Linking in a Mouse Model: Biomechanical and Morphological Evaluation. CXL congress 2014, Zurich, Switzerland

Hammer A., Rudaz S, Guinchard S, Kling S, Tabibian D, Richoz O, Hafezi F. Determining stromal riboflavin concentrations. CXL congress 2014, Zurich, Switzerland

Hammer A., Richoz O, Arbra-Mosquera S, Gatzioufas Z, Hafezi F. Corneal Collagen Cross linking Oxygen Dependency. ASCRS 2014, Boston, MA, USA

Richoz O, Hoogewoud F, Tabibian D, Hammer A, Hafezi F. Optimizing fluence settings and riboflavin composition for collagen cross-linking (CXL) in the antimicrobial efficiency against Pseudomonas aeruginosa and Staphylococcus aureus. SFO 2014, Paris, France

Hammer A., Hafezi F. HPLC and Optoacoustics to Determine Riboflavin Content in the Stroma. Congress of CXL 2013, Dublin, Ireland

Hammer A., Richoz O, Tabibian D, Hafezi F. CXL is an oxygen dependent process. Congress of CXL 2013, Dublin, Ireland

Hammer A., Richoz O, Hoogewoud F, Hafezi F. Corneal Biomechanical Properties at Different CXL-Fluences. ESCRS 2013, Amsterdam, Netherlands

Hammer A., Richoz O, Tabibian D, Hafezi F. The increase in biomechanical stiffness in corneal collagen cross-linking is oxygen dependent. ESCRS 2013, Amsterdam, Netherlands

Hammer A., Richoz O, Tabibian D, Hafezi F. Corneal Biomechanical Properties at Different CXL-Fluences. ARVO 2013, Seattle, Washington, USA

Richoz O, Hammer A, Hafezi F. Corneal Biomechanical Properties at Different CXL-Fluences. 8th int. Congress of CXL, Geneva, Switzerland

Hammer A. Central Serous Maculopathy, Pathophysiology – clinical aspects – workup and treatment. Grand Rounds, HUG, Ophthalmology Department, Geneva, Switzerland, 2011

Hammer A. Pellucid marginal degeneration (PMD): Pathophysiology – clinical aspects – workup – treatment and case report. Grand Rounds, Ophthalmology Department, Geneva, Switzerland, 2011

Hammer A. Onchocerciasis (River blindness) – Epidemiology – Pathophysiology – clinical aspects – workup and treatment. Teaching lecture, HUG, Ophthalmology Department, Geneva, Switzerland, 2011

Hammer A. VI Nerve Palsy in Idiopathic Intracranial Hypertension – Epidemiology – Pathophysiology – clinical aspects – workup and treatment. Teaching lecture, Ophthalmology Department, Geneva, Switzerland, 2011

Hammer A. Moderator of the session « Laser and Cataract Surgery: What you should Know”. The Cataract Circle Meeting. November 2024. Zurich, Switzerland

Hammer A. Moderator of the free paper session « Corneal Biomechanics ». ESCRS annual meeting 2013, Amsterdam, Netherlands

Hammer A., Heeren T, Angunawela R, Kamran S. Predicting refractive correction of a prior LASIK treatment from corneal pachymetry profile. ESCRS winter meeting, Amsterdam. February 2022.

Hammer A., Heeren T, Angunawela R, Kamran S. Predicting refractive correction of a prior LASIK treatment from corneal pachymetry profile. Bowman club annual meeting, Cambridge, UK. March 2022.

Hammer A., Astete Rios M, Rahman A, Vasquez-Perez A. Cornea guttata in donor material: is there a need for improvement in the eye bank screening? Bowman club annual meeting, Cambridge, UK. March 2022.

E.Torres-Netto, S. Kling, Hammer A., S. Arba Mosquera, T. Magnago, N. Hafezi, F. Hafezi. Stromal bed smoothness after excimer laser surface ablation as a key element for the expression of inflammatory genes. ESCRS 2019, Paris, France

Hammer A., Ruiz-Medrano J, Schalenbourg A. PHACE syndrom: case report of an ‘atypical Sturge-Weber’ patient. SSO 2018, Davos, Suisse

Hammer A., Wolfensberger T. ARTISAN lens implantation with novel approach for aphakia after previous filtration surgery. SSO 2016, Interlaken, Suisse

Hammer A., Rudaz S, Guinchard S, Kling S, Tabibian D, Richoz O, Hafezi F. UPLC analysis of stromal riboflavin concentrations in epi-off and epi-on corneal cross-linking. ESCRS 2015, Barcelona, Spain

Hammer A., Rudaz S, Guinchard S, Kling S, Tabibian D, Richoz O, Hafezi F. Determining stromal riboflavin concentrations. SSO/SOG 2015, Fribourg Switzerland

Hammer A., Kling S, Boldi M-O, Richoz O, Tabibian D, Randleman J-B, Hafezi F. Establishing Corneal Cross-Linking with riboflavin and UV-A in the mouse cornea in vivo: biomechanical analysis. SSO/SOG 2015, Fribourg Switzerland

Kling S, Hammer A., Richoz O, Hafezi F. The Effect of pulsed UV Corneal Cross-linking (CXL) on Corneal Biomechanics. SSO/SOG 2015, Fribourg Switzerland

Kling S, Hammer A., Tabibian D, Richoz O, Agarwal A, Jacob S, Hafezi F. Optimizing UV Cross-Linking Protocols for Thin Corneas. SSO/SOG 2015, Fribourg Switzerland

Hammer A., Rudaz S, Guinchard S, Kling S, Tabibian D, Richoz O, Hafezi F. Determining stromal riboflavin concentrations for epi-off and epi-on formulations using UPLC (Ultra Performance Liquid Chromatography). ARVO 2015, Denver (CO, USA)

Tabibian D, Kling S, Hammer A., Richoz O, Hafezi F. No additional biomechanical effect of CXL after repeated in vivo treatment in mice. ARVO 2015, Denver (CO, USA)

Kling S, Hammer A., Tabibian D, Richoz O, Agarwal A, Jacob S, Hafezi F. Biomechanical Efficacy of UV Cross-Linking Protocols in Thin versus Thick Corneas: The Effect of Oxygen, UV Absorption and Osmotic Pressure. ARVO 2015, Denver (CO, USA)

Richoz O, Hoogewoud F, Tabibian D, Hammer A., Hafezi F. Optimizing fluence settings and riboflavin composition for collagen cross-linking (CXL) in the antimicrobial efficiency against Pseudomonas aeruginosa and Staphylococcus aureus. ARVO 2014, Orlando, Florida, USA

Hammer A., Richoz O, Tabibian D, Hafezi F. The increase in biomechanical stiffness in corneal collagen cross-linking is oxygen dependent. AAO 2013, New-Orleans, Louisiana

Hammer A., Mosquera S, Magnano T, Richoz O, Tabibbian T, Hafezi F. Corneal biomechanical properties at different CXL fluences. SSO/SOG 2013, Locarno, Switzerland

Hammer A., Richoz O, Tabibbian T, Gatzioufas Z, Hafezi F. Corneal Collagen Cross-Linking (CXL) is Oxygen dependent. SSO/SOG 2013, Locarno, Switzerland

Hafezi F, Gatzioufas Z, Hammer A., Tabibian D, Richoz O. Fluorescein competes riboflavin in CXL for the treatment of infectious keratitis. ARVO 2013, Seattle, Washington, USA

Tabibian D, Richoz O, Spoerl E, Hammer A., Hoogewoud F, Hafezi F. A new technique to measure corneal biomechanical changes after corneal collagen cross-linking. ARVO 2013, Seattle, Washington, USA

Richoz O, Hammer A., Hafezi F. Corneal Biomechanical Properties at Different CXL-Fluences. ASCRS 2013, San Francisco, California, USA

February 2024 – Blick.ch : Un médecin nous explique tout sur la sécheresse oculaire